Diazoxide-resistant hyperinsulinism

MONDO:0017186

Diazoxide-resistant hyperinsulism (DRH) is form of congenital isolated hyperinsulism caused by an abnormal insulin production by B-cells in the pancreas that can be diffuse or focal and is characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), recurrent episodes of profound hypoglycemia and resistance to medical management with diazoxide.

Also known as: diazoxide-resistant hyperinsulinemic hypoglycemia

40 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Broader categories

Sort by